For instance, obesity-related factors such as elevated levels of pro-inflammatory cytokines (e.g., IL-6, TNF-α) and adipokines (e.g., leptin) may promote an immune-stimulatory environment that facilitates a stronger anti-tumor response when ICIs are administered.216. This evidence concerns the gene IL6 and obesity disorder.